Journey Medical Corporation has announced that the FDA has approved Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the treatment of inflammatory lesions of rosacea in adults. The product was developed in collaboration with Dr. Reddy’s Laboratories Ltd., and aims to deliver a new standard of care for patients suffering from this skin condition.
Company Information
Company
Journey Medical Corporation
Location
9237 E VIA DE VENTURA BLVD.
Scottsdale, Arizona, United States
About
Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”) is a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions through its efficient sales and marketing model. The Company currently markets eight FDA approved prescription drugs that help treat and heal common skin conditions. The Journey Medical team comprises industry experts with extensive experience in developing and commercializing some of dermatology’s most successful prescription brands. Journey Medical is located in Scottsdale, Arizona and was founded by Fortress Biotech, Inc. (Nasdaq: FBIO). Journey Medical’s common stock is registered under the Securities Exchange Act of 1934, as amended, and it files periodic reports with the U.S. Securities and Exchange Commission (“SEC”).
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Journey Medical Corporation ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
ScottsdaleBiotechnologyHealthcareHealth CarePharmaceutical